Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01758510
Recruitment Status : Completed
First Posted : January 1, 2013
Last Update Posted : May 16, 2019
Sponsor:
Collaborator:
Corestem, Inc.
Information provided by (Responsible Party):
Seung Hyun Kim, Hanyang University Seoul Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 10, 2017
Actual Study Completion Date : April 10, 2017
Publications: